AKT1 and breast carcinoma: Genetic mutations and the dysregulation of cell signaling pathways, particularly the PI3K-AKT signaling pathway, exert a major function in initiation and progression of breast cancer, with the latter being the most frequently upregulated pathway in the disease according to previous research [21].